Detection of Isolated Tumor Cells in Bone Marrow Is an Independent Prognostic Factor in Breast Cancer
- 15 September 2003
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 21 (18) , 3469-3478
- https://doi.org/10.1200/jco.2003.02.009
Abstract
Purpose: This study was performed to disclose the clinical impact of isolated tumor cell (ITC) detection in bone marrow (BM) in breast cancer.Keywords
This publication has 26 references indexed in Scilit:
- Epithelial Cells in Bone Marrow of Breast Cancer Patients at Time of Primary Surgery: Clinical Outcome During Long-Term Follow-UpJournal of Clinical Oncology, 2001
- Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast CancerNew England Journal of Medicine, 2000
- Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up studyThe Lancet, 1999
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Meta-analyses of studies on bone marrow micrometastases: an independent prognostic impact remains to be substantiated.Journal of Clinical Oncology, 1998
- Micrometastatic Breast Cancer Cells in Bone Marrow at Primary Surgery: Prognostic Value in Comparison With Nodal StatusJNCI Journal of the National Cancer Institute, 1996
- Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-upBritish Journal of Cancer, 1994
- Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases.Journal of Clinical Oncology, 1991
- Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases.BMJ, 1987